Ozempic has gone from a diabetes medication to one of the most talked-about weight-loss drugs in the world. But as the popularity of GLP-1 medications continues to soar, one doctor is warning that more is not necessarily better. Functional medicine expert Dr. Will Cole recently compared an excessively high dose of a GLP-1 peptide to an “atomic bomb”, arguing that aggressively shutting down hunger signals may not be the answer to improving metabolic health. His comments, reported by media outlet, come amid growing interest in using GLP-1 drugs not just for weight loss, but also for potential effects on inflammation, metabolism and healthy ageing. The comparison is an analogy, not a claim that Ozempic literally becomes an atomic bomb. Cole’s concern centres on what can happen when appetite suppression becomes excessive or when people view higher doses as a shortcut to faster weight loss. Read More: FDA Approves Once-Daily Parkinson’s Pill Juvmo: What Patients Need To Know GLP-1 medicines work partly by acting on appetite and digestion. Semaglutide, the active ingredient in Ozempic and Wegovy, can increase feelings of fullness and slow stomach emptying, helping people eat less. In clinical research, a 2.4 mg weekly dose of semaglutide produced significant weight loss in adults with overweight or obesity, although nausea, diarrhoea and other gastrointestinal problems were among the most common side effects. That does not mean higher doses should automatically be considered dangerous. The FDA-approved products have specific dosing schedules, with gradual dose increases designed to help the body adjust. The current FDA prescribing information for injectable Wegovy, for example, describes starting at a low weekly dose and increasing it at four-week intervals, with maintenance dosing determined by the indication and patient response. Taking more medication than prescribed can increase the likelihood of side effects, particularly gastrointestinal symptoms such as nausea, vomiting, diarrhoea, constipation and abdominal pain. Semaglutide treatment also carries warnings and precautions involving conditions including pancreatitis, gallbladder disease and kidney problems related to dehydration. There is another concern hidden behind the dramatic “atomic bomb” phrase: hunger itself is not inherently abnormal. Cole argued that eliminating hunger cues completely may encourage an unhealthy relationship with food, particularly if medication replaces nutrition, exercise and other lifestyle measures. He suggested that researchers should continue studying approaches involving lower doses, cycling treatment and combining medication with lifestyle changes. For people prescribed Ozempic or another GLP-1 medication, the takeaway is not to panic about the drug — or change the dose based on something seen online. These medicines have been studied extensively and can be effective when appropriately prescribed. The important question is not simply how much weight someone can lose, but what dose provides an appropriate balance between benefit, side effects, nutrition and long-term health. So, can Ozempic really become an 'atomic bomb?' No, that is a doctor’s metaphor. But the warning behind it is worth paying attention to: with powerful medicines, chasing a bigger dose does not automatically mean getting a better result. Read More: Creatine May Build Muscle Even If You Don’t Exercise, New Study Finds Simran covers books that start conversations, beauty insights, fashion moods, and stories that make people feel something. Off duty? You’ll find her c... View More